Gelteq Limited Ordinary Shares
GELS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.95M
Close$
$-0.28
156.6% downside
Current Fair Value
156.6% downsideOvervalued by 156.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.95 Million |
|---|---|
| Enterprise Value | $9.08 Million |
| Earnings per Share | $0 |
| Beta | -0.39 |
| Outstanding Shares | 10,394,733 |
Return
| Return on Equity | -39.45% |
|---|---|
| Return on Assets | -27.84% |
| Return on Invested Capital | -35.83% |
Valuation & Multiples
| P/E Ratio | -1.15 |
|---|---|
| PEG | -1.77 |
| Price to Sales | - |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | 50.83 |
| Enterprise Value to EBIT | -1.78 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.57 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Gelteq Limited Ordinary Shares
18 employees
CEO: Nathan Jacob Givoni
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formul...